OBJECTIVE: This study aimed to evaluate the accuracy of endoscopic ultrasound (EUS) and cross-sectional imaging including multidetector computed tomography (MDCT) or magnetic resonance imaging (MRI) as a preoperative diagnostic modality for the pancreatic cystic lesions. METHODS: Three hundred eighteen patients with surgically proven pancreatic cystic lesions were enrolled as a study cohort from 1998 to 2011. Preoperative radiological, EUS, and final histopathologic diagnosis were correlated to measure several kinds of diagnostic performance. RESULTS: A total of 318 patients underwent preoperative MDCT, with additional imaging modalities such MRI and/or EUS in 215 (67.6%) and 108 (34.0%) patients, respectively. κ Values among the different modalities were as follows: MDCT versus pathology = 0.52 (P < 0.0001), MDCT + MRI versus pathology = 0.674 (P < 0.0001), and EUS versus pathology = 0.558 (P < 0.0001). The sensitivity and specificity in terms of ability to predict neoplastic cysts were as follows: MDCT, 83.1%/70.0%; MDCT + MRI, 94.7%/58.7%; and EUS, 88.5%/52.9%. The diagnostic accuracies of MDCT and MDCT + MRI were 61.4% (62/101) and 80.5% (173/215), respectively, and that of EUS was 70.4% (76/108). CONCLUSIONS: Magnetic resonance imaging as an additional diagnostic modality to MDCT increased the accuracy, sensitivity, and specificity, as well in terms of predicting neoplastic cysts.
OBJECTIVE: This study aimed to evaluate the accuracy of endoscopic ultrasound (EUS) and cross-sectional imaging including multidetector computed tomography (MDCT) or magnetic resonance imaging (MRI) as a preoperative diagnostic modality for the pancreatic cystic lesions. METHODS: Three hundred eighteen patients with surgically proven pancreatic cystic lesions were enrolled as a study cohort from 1998 to 2011. Preoperative radiological, EUS, and final histopathologic diagnosis were correlated to measure several kinds of diagnostic performance. RESULTS: A total of 318 patients underwent preoperative MDCT, with additional imaging modalities such MRI and/or EUS in 215 (67.6%) and 108 (34.0%) patients, respectively. κ Values among the different modalities were as follows: MDCT versus pathology = 0.52 (P < 0.0001), MDCT + MRI versus pathology = 0.674 (P < 0.0001), and EUS versus pathology = 0.558 (P < 0.0001). The sensitivity and specificity in terms of ability to predict neoplastic cysts were as follows: MDCT, 83.1%/70.0%; MDCT + MRI, 94.7%/58.7%; and EUS, 88.5%/52.9%. The diagnostic accuracies of MDCT and MDCT + MRI were 61.4% (62/101) and 80.5% (173/215), respectively, and that of EUS was 70.4% (76/108). CONCLUSIONS: Magnetic resonance imaging as an additional diagnostic modality to MDCT increased the accuracy, sensitivity, and specificity, as well in terms of predicting neoplastic cysts.
Authors: Lawrence Mj Best; Vishal Rawji; Stephen P Pereira; Brian R Davidson; Kurinchi Selvan Gurusamy Journal: Cochrane Database Syst Rev Date: 2017-04-17
Authors: Jin Ho Choi; Sang Hyub Lee; Young Hoon Choi; Jinwoo Kang; Woo Hyun Paik; Dong-Won Ahn; Ji Kon Ryu; Yong-Tae Kim Journal: Therap Adv Gastroenterol Date: 2018-03-07 Impact factor: 4.409
Authors: Nan Ge; William R Brugge; Payal Saxena; Anand Sahai; Douglas G Adler; Marc Giovannini; Nonthalee Pausawasdi; Erwin Santo; Girish Mishra; William Tam; Mitsuhiro Kida; Jose G de la Mora-Levy; Malay Sharma; Muhammad Umar; Akio Katanuma; Linda Lee; Pramod Kumar Garg; Mohamad Ali Eloubeidi; Ho Khek Yu; Isaac Raijman; Brenda Lucia Arturo Arias; Manoop Bhutani; Silvia Carrara; Praveer Rai; Shuntaro Mukai; Laurent Palazzo; Christoph F Dietrich; Nam Q Nguyen; Mohamed El-Nady; Jan Werner Poley; Simone Guaraldi; Evangelos Kalaitzakis; Luis Carlos Sabbagh; Jose Lariño-Noia; Frank G Gress; Yuk-Tong Lee; Surinder S Rana; Pietro Fusaroli; Michael Hocke; Vinay Dhir; Sundeep Lakhtakia; Thawee Ratanachu-Ek; A S Chalapathi Rao; Peter Vilmann; Hussein Hassan Okasha; Atsushi Irisawa; Ryan Ponnudurai; Ang Tiing Leong; Everson Artifon; Julio Iglesias-Garcia; Adrian Saftoiu; Alberto Larghi; Carlos Robles-Medranda; Siyu Sun Journal: Endosc Ultrasound Date: 2019 Nov-Dec Impact factor: 5.628